Document Type: Short communication

Authors

1 Institute of Organic Chemistry and Chemical Biology, Center for Biomolecular Magnetic Resonance, Johann Wolfgang Goethe-University Frankfurt, Max-von-Laue-Straße 7, D-60438 Frankfurt am Main, Germany

2 Swiss Tropical and Public Health Institute, Socinstrasse 57, CH-4051 Basel, Switzerland

3 University of Basel, Petersplatz 1, CH-4003 Basel, Switzerland

Abstract

A set of conformationally restricted analogues of the natural product primin were synthesized as potential antiprotozoal agents. The synthesis utilizes quinone C-H functionalization methods to enable an efficient and easy access to primin analogues. The antiprotozoal activities of this series were evaluated in a panel of parasites and compared with the natural product primin. For all synthesized primin analogues a potent in vitro activity was found against the pathogen Trypanosoma brucei rhodesiense (IC50 < 0.05 µg/mL). The observed antiprotozoal activity is not related to production of reactive oxygen species (ROS). Initial results of the in vivo experiments with a T. b. rhodesiense rodent animal model of the human disease were also reported. Intraperitoneal injection administration of compound 7 resulted in complete clearance of T. b. rhodesiense in tested rodent animals 24 hours after the last treatment. Our results show that the primin scaffold represents a new scaffold for further development of potent inhibitors of Trypanosoma brucei rhodesiense.

Graphical Abstract

Keywords

Main Subjects

  1. H. Schildknecht, I. Bayer, Schmidt Zeitschrift für Naturforsch. Part B-Chemie Biochem. Biophys. Biol. und verwandten Gebieten1967, B22 (1), 36.
  2. G.Guella, I. Mancini, F. Pietra, Helv. Chim. Acta1987, 70 (3), 621.
  3. P. Moosophon, S. Kanokmedhakul, K. Kanokmedhakul, J. Nat. Prod.2011, 74 (10), 2216.
  4. Y. Hong, S. Sengupta, W. Hur, T. Sim,J. Med. Chem.2015, 58 (9), 3739.
  5. I.-K. Lee, B.-S. Yun, S.-M. Cho, W.-G. Kim, J.P. Kim, I.-J. Ryoo, H. Koshino, I.D. Yoo, J. Nat. Prod.1996, 59 (11), 1090.
  6. A. A. L. Gunatilaka, J. M. Berger, R. Evans, J. S. Miller, J. H. Wisse, K. M. Neddermann, I. Bursuker, D. G. I. Kingston, J. Nat. Prod.2001, 64 (1), 2.
  7. D. Tasdemir, R. Brun, V. Yardley, S. G. Franzblau, P. Rüedi, Chem. Biodivers.2006, 3 (11), 1230.
  8. M.S. Butler, Nat. Prod. Rep.2005, 22 (2), 162.
  9. D. J. Newman, G. M. Cragg, J. Nat. Prod.2016, 79 (3), 629.
  10. Y. Hata,M. Raith, S. Ebrahimi, S. Zimmermann, T. Mokoka, D. Naidoo, G. Fouche, V. Maharaj, M. Kaiser, R. Brun, et al. Planta Med.2013, 79 (06), 492.
  11. A. Bhattacharya, T. Kaur, K. Ganesh, Synthesis (Stuttg).2010, 2010 (07), 1141.
  12. A. Gunatilaka, J. Berger, R. Evans, J. Miller, J. Wisse, K. Neddermann, I. Bursuker, D. Kingston,J. Nat. Prod.2001, 64 (1), 2.
  13. L. W. Bieber, A. de Andrade Chiappeta, M. A. de Moraes e Souza, M. Generino, P. R. Neto, J. Nat. Prod.1990, 53 (3), 706.
  14. H. Nasiri, J. Ferner, C. Tukek, S. Krishnathas, H. Schwalbe,Tetrahedron Lett.2015, 56 (17), 2231.
  15. J. M. Saa, J. Morey, C. Rubido, C. J. Org. Chem.1986, 51 (23), 4471.
  16. T. T. Wager, X. Hou, P. R. Verhoest, A. Villalobos, ACS Chem. Neurosci.2010, 1 (6), 435.
  17. F. Fonseca-Silva, J. D. F. Inacio, M. M. Canto-Cavalheiro,  E. E. Almeida-Amaral, J. Nat. Prod.2013, 76 (8), 1505.
  18. F. Fonseca-Silva, M. M. Canto-Cavalheiro, R. F. S. Menna-Barreto, E. E. Almeida-Amaral, J. Nat. Prod.2015, 78 (4), 880.
  19. J. B. Baell, J. Nat. Prod.2016, 79 (3), 616.
  20. H. R. Nasiri, P. Mracek, S. K. Grimm, J. Gastaldello,  A. Kolodzik, D. Ullmann, Medchemcomm2017, 8 (6), 1220.
  21. H. Nasiri, K. Hohmann, M. Hatemler, A. Plodek, F. Bracher, H. Schwalbe, Med. Chem. Res.2017, 26 (6), 1170.
  22. Caution: Primin (1) and its analogues are skin sensitizers. The contact with skin should be avoided. 2
  23. Biological assaysIn vitro activity. The in vitro activity of the compounds were determinded against
  24. Y. Fujiwara, V. Domingo, I. B. Seiple, R. Gianatassio, M. Del Bel, P.S. Baran, J.Am.Chem.Soc.2011, 133, 3292.
  25. I. Orhan, B. Şener, M. Kaiser, R. Brun, D. Tasdemir, Mar. Drugs2010, 8 (1), 47.
  26. M. Kaiser, M.A. Bray, M. Cal, B. Bourdin Trunz, E. Torreele, R. Brun, Antimicrob. Agents Chemother. 2011, 55 (12), 5602.